Last 12 months
Inside the activity.
1 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 6 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 9 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 07, 2025 Filed Aug 12, 2025 01:01 UTC |
Farquhar John C.M.Director · Chief Executive Officer
|
GrantCommon Stock | 59,868 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-039735 · wk-form4_1754960473.xml · nonDerivative · entry 1 Farquhar John C.M. · CIK 0001900415 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 433,248 F1 · shares: Represents restricted stock units ("RSUs"), with a vesting commencement date of August 7, 2025 (the "Vesting Commencement Date"). 1/16th of the RSUs vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date. Read SEC document |
| August 07, 2025 Filed Aug 12, 2025 01:00 UTC |
Jones Marie L.Chief Accounting Officer, VP
|
GrantStock Option · Derivative | 19,014 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0001628280-25-039732 · wk-form4_1754960452.xml · derivative · entry 4 Jones Marie L. · CIK 0001968991 · Chief Accounting Officer, VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,014 Underlying: Common Stock · 19,014 shares Expires 2035-08-07 F4 · derivative.exercise_date: The option vests 1/48 on each monthly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date. Read SEC document |
| August 07, 2025 Filed Aug 12, 2025 01:00 UTC |
Jones Marie L.Chief Accounting Officer, VP
|
GrantCommon Stock | 3,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-039732 · wk-form4_1754960452.xml · nonDerivative · entry 1 Jones Marie L. · CIK 0001968991 · Chief Accounting Officer, VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,618 F1 · shares: Represents restricted stock units ("RSUs"), with a vesting commencement date of August 7, 2025 (the "Vesting Commencement Date"). 1/16th of the RSUs vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date. Read SEC document |
| August 07, 2025 Filed Aug 12, 2025 01:01 UTC |
Rogers CampbellChief Medical Officer
|
GrantStock Options · Derivative | 110,629 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0001628280-25-039733 · wk-form4_1754960459.xml · derivative · entry 6 Rogers Campbell · CIK 0001585724 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,629 Underlying: Common Stock · 110,629 shares Expires 2035-08-07 F2 · derivative.exercise_date: The option vests 1/48 on each monthly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date. Read SEC document |
| August 07, 2025 Filed Aug 12, 2025 01:01 UTC |
Rogers CampbellChief Medical Officer
|
GrantCommon Stock | 21,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-039733 · wk-form4_1754960459.xml · nonDerivative · entry 1 Rogers Campbell · CIK 0001585724 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,052 F1 · shares: Represents restricted stock units ("RSUs"), with a vesting commencement date of August 7, 2025 (the "Vesting Commencement Date"). 1/16th of the RSUs vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date. Read SEC document |
| August 07, 2025 Filed Aug 12, 2025 01:00 UTC |
BARABE TIMOTHY CDirector
|
GrantStock Option · Derivative | 23,710 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0001628280-25-039731 · wk-form4_1754960446.xml · derivative · entry 2 BARABE TIMOTHY C · CIK 0001237409 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,710 Underlying: Common Stock · 23,710 shares Expires 2035-08-07 F2 · derivative.exercise_date: The option will vest in full on the earlier of Heartflow's annual meeting of shareholders in 2026 and the first anniversary of the grant date, subject to continued service through such date. Read SEC document |
| August 07, 2025 Filed Aug 12, 2025 01:00 UTC |
Lightcap Jeffrey CDirector
|
GrantStock Option · Derivative | 47,420 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0001628280-25-039729 · wk-form4_1754960433.xml · derivative · entry 12 Lightcap Jeffrey C · CIK 0001519465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,420 Underlying: Common Stock · 47,420 shares Expires 2035-08-07 F7 · derivative.exercise_date: The option will vest in full on the earlier of Heartflow's annual meeting of shareholders in 2026 and the first anniversary of the grant date, subject to continued service through such date. Read SEC document |
| March 13, 2025 Filed Aug 12, 2025 01:00 UTC |
Jones Marie L.Chief Accounting Officer, VP
|
GrantStock Option · Derivative | 68,492 | $0.00 Strike: $12.68 | $0.00 |
DisclosureSEC source: 0001628280-25-039732 · wk-form4_1754960452.xml · derivative · entry 3 Jones Marie L. · CIK 0001968991 · Chief Accounting Officer, VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,492 Underlying: Common Stock · 68,492 shares Expires 2035-03-13 F3 · derivative.exercise_date: 1/4th of the options will vest on January 8, 2026, and the remaining shares will vest and become exercisable in monthly installments until January 8, 2029, subject to continued service through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.